DF/HCC Specialized Program of Research Excellence (SPORE) in Brain Cancer - RFA

JANUARY 9, 2023

The Neuro-Oncology Program at Dana-Farber/Harvard Cancer Center (DF/HCC) is seeking scientific project applications for potential incorporation into our National Cancer Institute (NCI)-sponsored Specialized Program of Research Excellence (SPORE) grant, Targeted Therapies for Glioma. Projects are typically funded with a budget of ~$175,000 (direct costs) per year. The proposed projects can be focused on either adult or pediatric gliomas. Applications are due February 20, 2023. Read more about this award below for more information.

Scientific Project RFA

 

REQUEST FOR APPLICATIONS: Scientific Project in Brain Cancer
AWARD AMOUNT:

Projects are typically funded with a budget of ~$175,000 (direct costs) per year

APPLICATION DEADLINE: On or before Monday, February 20, 2023

The Neuro-Oncology Program at Dana-Farber/Harvard Cancer Center (DF/HCC) is seeking scientific project applications for potential incorporation into our National Cancer Institute (NCI)-sponsored Specialized Program of Research Excellence (SPORE) grant, Targeted Therapies for Glioma. Projects are typically funded with a budget of ~$175,000 (direct costs) per year. The proposed projects can be focused on either adult or pediatric gliomas.

Applicants must be faculty members at Harvard Medical School or Harvard School of Public Health at the level of Instructor or higher. While the proposed research may be basic or clinical, bench-to-bedside or bedside-to-bench strategies must be addressed in the application, as the ultimate purpose of the program is to promote translational research and clinical trials in gliomas. Responses to this request for applications will be judged on their scientific merit and relevance to the overall mission of the DF/HCC glioma SPORE.

The application deadline is February 20, 2023. Our SPORE Advisory Committee will select 3 to 4 projects by March 20, 2023, to be included in our competing renewal application, which will be submitted to NCI in September 2023 by Brigham and Women’s Hospital as the primary institution.

An application for the February 20 deadline consists of the following components, to be submitted as single PDF document:

  1. Abstract (1 page maximum)
  2. Research Plan (3 pages maximum excluding references): Specific Aims, Background and Relevance to Gliomas, Preliminary Data, Experimental Methods, Analysis Plan
  3. NIH Biosketch of Principal Investigator(s) (Use the New 2022 format) and other Key Personnel
  4. Budget and Budget Justification (1 page maximum)

Applications should be submitted to Paul Mintz, Ph.D. (pmintz@bwh.harvard.edu). Minority and women applicants are strongly encouraged to apply.

Hide